The CRISPR patent dispute between the University of California, Berkeley, and the Broad Institute is finally over

Quick Read

A desperate but determined group of parents raised millions through golf tournaments and cocktail parties to support research for drugs to fight cystinosis, a rare, fatal childhood disease. They were ecstatic when a pill called Procysbi was approved in 2013

Quick Read

Even when a town wants to open a new hospital to make up for a lack of health care, the challenges can be enormous

Quick Read

So they’re starting their own. A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a mission-driven, not-for-profit generic drug company, Civica Rx, to take some control over the drug supply

Quick Read

The new health care venture formed by Amazon, Berkshire Hathaway and JPMorgan Chase announced June 20 that Harvard professor and well-known author Atul Gawande would be the company’s CEO. The idea for the new company is to innovate by cutting costs from the health care system, starting with the more than 1 million employees of the three companies behind the venture

Quick Read

The Food and Drug Administration defines a drug shortage as a “period of time when the demand or projected demand for a medically necessary drug in the U.S. exceeds its supply.” All too often, a shortage means that doctors cannot give the right drugs to patients when needed

Quick Read

Depending on whom you ask, Addyi is the overdue answer to an unmet need or just another way to shame women

Quick Read

Several new scientific studies out today confirm what NPR News first reported. Hundreds of coal miners are suffering from the advanced stage of the fatal disease commonly called black lung. This epidemic of severe disease seems to be getting worse. NPR’s Howard Berkes has the new findings

Quick Read